Researcher
Beppe Floris
- Disciplines:Macromolecular and materials chemistry, Laboratory medicine, Morphological sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From29 Oct 2007 → 2 Feb 2011 - Translational Cell & Tissue Research (Division)
Member
From12 May 2004 → Today
Projects
1 - 10 of 20
- Atlas of therapeutic targets in metastatic breast cancer.From1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- The changing HER2 biomarker testing policy: Impact and training for the Belgian pathology laboratoriesFrom12 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- MetLob: A post-mortem tissue donation study dedicated to Metastatic Lobular breast cancerFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Histopathological heterogeneity of metastatic breast cancerFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Quality improvement of diagnostic processes in the oncology fieldFrom18 Oct 2021 → 15 Jan 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Molecular characterization of the tumor microenvironment of breast cancer metastasesFrom11 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- UPTIDER (UZ/KU Leuven Program for post-mortem Tissue Donation to Enhance Research), a unique setting to unravel treatment resistance and disease progression in patients with breast cancer.From1 Oct 2021 → TodayFunding: BOF - projects
- FAT-IBC: Facing adiposity in personalizing treatment of Inflammatory Breast Cancer patients.From1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Improving immuno-oncology diagnostics by high-dimensional correlation analysis of histopathology and proteomics data in breast cancer samplesFrom4 Sep 2020 → 22 Feb 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Clinical, pathological and molecular characterization of invasive lobular carcinoma (ILC)From12 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
121 - 130 of 169
- Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization(2015)
Authors: Chunshu Li, Diether Lambrechts, Patrick Neven, Hans Wildiers, Beppe Floris
- Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression(2015)
Authors: Beppe Floris, Diether Lambrechts
Pages: 22 - 34 - Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2(2015)
Authors: Nick Orr, Frank Dudbridge, Nicola Dryden, Sarah Maguire, Daniela Novo, Eleni Perrakis, Nichola Johnson, Maya Ghoussaini, John L Hopper, Melissa C Southey, et al.
Pages: 2966 - 84 - Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2(2015)
Authors: Diether Lambrechts, Matthieu Moisse, Beppe Floris, Benoit Beuselinck
Pages: 2966 - 84 - Therapeutic Efficacy Assessment of CK6, a Monoclonal KIT Antibody, in a Panel of Gastrointestinal Stromal Tumor Xenograft Models(2015)
Authors: Thomas Van Looy, Agnieszka Wozniak, Beppe Floris, Haifu Li, Jasmien Wellens, Ulla Vanleeuw, Raf Sciot, Maria Debiec-Rychter, Patrick Schöffski
Pages: 112 - 8 - Therapeutic Efficacy Assessment of CK6, a Monoclonal KIT Antibody, in a Panel of Gastrointestinal Stromal Tumor Xenograft Models(2015)
Authors: Thomas Van Looy, Agnieszka Wozniak, Beppe Floris, Haifu Li, Raf Sciot, Maria Debiec-Rychter, Patrick Schöffski
Pages: 112 - 8 - Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors(2015)
Authors: Beppe Floris, Karin Leunen, Diether Lambrechts
Pages: E685 - E696 - The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014(2015)
Authors: Beppe Floris
Pages: 259 - 271 - Withdrawal of hormone replacement therapy might affect multigene signature results in early luminal breast cancer(2015)
Authors: Patrick Neven, Lynn Jongen, Beppe Floris, Hans Wildiers
Pages: 437 - 438 - Phosphoinositide 3-kinase inhibitors combined with imatinib in patient-derived xenograft models of gastrointestinal stromal tumours: rationale and efficacy(2014)
Authors: Thomas Van Looy, Agnieszka Wozniak, Beppe Floris, Raf Sciot, Haifu Li, Maria Debiec-Rychter, Patrick Schöffski
Pages: 6071 - 82